CMB International Securities  Equity Research  Company Update
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Target Price
(Previous TP
UpDownside
Current Price
3 Jan 2022
Wayne Fung CFA
Mkt Cap (RMB mn)
Avg 3 mths to (RMB mn)
52w HighLow (RMB)
Total Issued Shares (mn)
Source Bloomberg
Shareholding Structure
Shenzhen Zhaoguang Inv
Ningbo Shunda Fengrun VC
Note Shenzhen Mingde is owned by WANG
Source Company data
Source Bloomberg
12-mth Price Performance
Source Bloomberg
Auditor PricewaterhouseCoopers
Related reports
1 China Express Delivery Sector 
Strong policy measures to reshape
to Outperform  1 Dec 2021
2 SF Holding (002352 CH HOLD) 
Further earnings downside risk
Wait for a better entry point  12 Apr
SHSZ300  (rebased)
exercise in 2021 Going forward with a focus on premium delivery service SF is
from pricing to service quality after the governments intervention Meanwhile
SFs strategic shift from scale to profitability together with the consolidation of
Kerry Logistics (636 HK NR) will boost significant earnings recovery in 2022E
delivery segment will boost SFs economy express volume We revise up our
earnings forecast in 2022E23E by 26%22% and lift our TP to RMB100 (based
on 61x 2022E PE) from RMB77 accordingly Upgrade to BUY from Hold
standard express is the key product of SF with a focus on the premium e-
of SFs total daily volume (excluding Kerry Logistics) based on our estimates
Given the rising demand for the improvement of delivery service we see
space We do not rule out the possibility for SF to initiate business relationship
Kerry Logistics interest in late Sep With the contribution from Kerry Logistics
SFs consolidated revenue from supply chain logistics grew 78x64x YoY in
OctNov We see strong synergies between SF and Logistics in China supply
chain logistics market given that the top three brands are all under SF We
estimate that supply chain logistics will account for 25% of SFs consolidated
revenue in 2022E
 Freight segment (less-than-truck-load) Focus on profit SF achieved
RMB580mn in 1H21 thanks to the shift of focus from scale to profit SF targets
to achieve profitable revenue growth of 20% in 2022E
 Major risks (1) Decline in ASP (2) further increase in operating cost (3)
delay of new business development
(YE 31 Dec)
Revenue (RMB mn)
YoY growth (%)
Core EPS (RMB)
YoY growth (%)
Consensus EPS (RMB)
EV  EBITDA (x)
Net gearing (%)
Source Company data Bloomberg CMBIS estimates
SF Holding-A (002352 CH)
Set to deliver strong earnings recovery in 2022E UG to BUY
3 Jan 2022
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 1 Change in key assumptions
Source Company data CMBIS
Figure 2 SFs ASP change versus industry
Source The State Post Bureau Company data CMBIS
Figure 3 SFs monthly parcel shipment growth
Source The State Post Bureau Company data CMBIS
Shipment volume (mn units of parcel)
Growth (YoY)
ASP (RMBunit)
Growth (YoY)
Unit cost (RMBunit)
Growth (YoY)
Unit gross margin (RMBunit)
Growth (YoY)
Revenue from express logistics
Revenue from supply chain
Express logistic  supply chain
Revenue from express logistics
Revenue from supply chain
Express logistic  supply chain
SD expense ratio
RD expense ratio
3 Jan 2022
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 4 Earnings sensitivity to ASP and unit outsourcing cost
Source Company data CMBIS estimates
Figure 5 Earnings sensitivity to ASP and unit transportation cost
Source Company data CMBIS estimates
Figure 6 Earnings sensitivity to ASP and unit employee cost
Source Company data CMBIS estimates
We believe the sluggish share price performance since 2Q21 has already reflected the
margin pressure and weak earnings in 2021E Our new TP of RMB100 is based on 61x
2022E PE 1SD above the historical average of 44x We believe SF deserves a valuation
premium given the strong earnings recovery in 2022E-23E Upgrade to BUY
Figure 7 SFs PE band
Source Bloomberg Company data CMBIS estimates
Figure 8 SFs PB band
Source Bloomberg Company data CMBIS estimates
2022E Net profit (RMB mn)
ASP (RMBunit)
Unit outsourcing cost
(RMBunit)
2022E Net profit (RMB mn)
ASP (RMBunit)
cost (RMBunit)
2022E Net profit (RMB mn)
ASP (RMBunit)
(RMBunit)
3 Jan 2022
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
YE 31 Dec (RMB mn)
FY23E  YE 31 Dec (RMB mn)
-655  Profit or loss of associates
SD expenses
-4260  Provision for impairment
Administrative expenses
-18022  Depreciation  amortization
RD expense
-655  Change in working capital
15313  Others
-765  Cash flow from operation
105  Net capex on PPE  intangibles
-870  Investment in JVassociates
Other gains(losses)
4587  Investment in subsidiaries
Share of profit of JV  associates
49  Interest received
19184  Others
-4662  Cash flow from investing
14522  Equity financing(repurchase)
-2904  Net bank borrowings
11618  Dividend paid
11618  Interest paid
11052  Others
26366  Cash flow from financing
Cash at beginning of the year
Exchange gains(losses)  others
Cash at the end of the year
YE 31 Dec (RMB mn)
FY23E  YE 31 Dec
Non-current assets
98845 103065  Sales mix (%)
55152  Revenue from express logistic
Investment properties
2219  Revenue from supply chain
Investment in JVassociates
5133  Sales of goods
Long term prepaid expense
4470  Others
6077  Total
Long term trade receivables
1459  Profit  loss ratio (%)
13773  Gross margin
5027  EBITDA margin
8215  EBIT margin
1539  After tax profit margin
70858  Growth (%)
2262  Revenue
Trade and bills receivables
35990  Gross profit
5796  EBITDA
Advances to suppliers
3177  EBIT
6277  Net profit
5248  Balance sheet ratio
12108  Current ratio (x)
57556  Receivable turnover days
Trade and bills payables
32630  Inventory turnover days
7531  Payable turnover days
9542  Net debt  total equity (%)
45 Net cash
1855  Profitability (%)
Advanced from customers
5968  ROE
Non-current liabilities
13592  Per share data
11291  EPS (RMB)
Deferred tax liabilities
1688  Core EPS (RMB)
Long term employee benefits
146  BVPS (RMB)
467  DPS (RMB)
Shareholders equity
Net cash includes financial investment     Source Company data CMBIS estimates
3 Jan 2022
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Disclosures  Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report in whole or in part certifies that with respect to the securities
or issuer that the analyst covered in this report (1) all of the views expressed accurately reflect his or her personal views about the subject securities
in this report
Besides the analyst confirms that neither the analyst nor hisher associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report (3) serve
covered in this report
CMBIS or its affiliate(s) have investment banking relationship with the issuers covered in this report in preceding 12 months
 Stock with potential return of over 15% over next 12 months
 Stock with potential return of 15% to -10% over next 12 months
 Stock with potential loss of over 10% over next 12 months
 Stock is not rated by CMBIS
OUTPERFORM                     Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM             Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM                 Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Securities Limited
Address 45F Champion Tower 3 Garden Road Hong Kong Tel (852) 3900 0888   Fax (852) 3900 0800
CMB International Securities Limited (CMBIS) is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary
of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities  The information contained in this report may not be suitable for the purposes of all investors  CMBIS does not
provide individually tailored investment advice This report has been prepared without regard to the individual investment objectives financial position or special
requirements  Past performance has no indication of future performance and actual events may differ materially from that which is contained in the report  The value
of and returns from any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets
consult with a professional financial advisor in order to make their own investment decisions
This report or any information contained herein have been prepared by the CMBIS solely for the purpose of supplying information to the clients of CMBIS or its affiliate(s)
to whom it is distributed  This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or enter into any
transaction  Neither CMBIS nor any of its affiliates shareholders agents consultants directors officers or employees shall be liable for any loss damage or expense
whatsoever whether direct or consequential incurred in relying on the information contained in this report  Anyone making use of the information contained in this report
does so entirely at their own risk
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable CMBIS
and forecasts on an AS IS basis  The information and contents are subject to change without notice CMBIS may issue other publications having information and or
report As a result recipients should be aware that CMBIS may have a conflict of interest that could affect the objectivity of this report and CMBIS will not assume any
responsibility in respect thereof This report is for the use of intended recipients only and this publication may not be reproduced reprinted sold redistributed or published
in whole or in part for any purpose without prior written consent of CMBIS
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended
from time to time)(The Order) or (II) are persons falling within Article 49(2) (a) to (d) (High Net Worth Companies Unincorporated Associations etc) of the Order and
may not be provided to any other person without the prior written consent of CMBIS
For recipients of this document in the United States
CMBIS is not a registered broker-dealer in the United States  As a result CMBIS is not subject to US rules regarding the preparation of research reports and the
independence of research analysts  The research analyst who is primary responsible for the content of this research report is not registered or qualified as a research
analyst with the Financial Industry Regulatory Authority (FINRA)  The analyst is not subject to applicable restrictions under FINRA Rules intended to ensure that the
analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report This report is intended for distribution in the United States
solely to major US institutional investors as defined in Rule 15a-6 under the US Securities Exchange Act of 1934 as amended and may not be furnished to any other
person in the United States Each major US institutional investor that receives a copy of this report by its acceptance hereof represents and agrees that it shall not
distribute or provide this report to any other person Any US recipient of this report wishing to effect any transaction to buy or sell securities based on the information
provided in this report should do so only through a US-registered broker-dealer
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte Limited (CMBISG) (Company Regn No 201731928D) an Exempt Financial Adviser as defined in the
Financial Advisers Act (Cap 110) of Singapore and regulated by the Monetary Authority of Singapore CMBISG may distribute reports produced by its respective foreign
entities affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations Where the report is distributed
in Singapore to a person who is not an Accredited Investor Expert Investor or an Institutional Investor as defined in the Securities and Futures Act (Cap 289) of
Singapore CMBISG accepts legal responsibility for the contents of the report to such persons only to the extent required by law Singapore recipients should contact
CMBISG at 65 6350 4400 for matters arising from or in connection with the report